Telix Pharmaceuticals Ltd

NEW
ASX:TLX (Australia)   Ordinary Shares
A$ 16.88 -0.30 (-1.75%) Jul 3
At Loss
P/B:
9.15
Market Cap:
A$ 5.72B ($ 3.96B)
Enterprise V:
A$ 6.19B ($ 4.29B)
Volume:
3.08M
Avg Vol (2M):
2.09M
Trade In:
Volume:
3.08M
At Loss

Telix Pharmaceuticals Ltd (ASX:TLX) Dividend

Telix Pharmaceuticals Ltd (ASX:TLX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:TLX Dividend

Does Telix Pharmaceuticals Ltd (ASX:TLX) pay a dividend?

Telix Pharmaceuticals Ltd (ASX:TLX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Telix Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Telix Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -2.3% over the past 3 years.

What are dividend-paying alternatives to Telix Pharmaceuticals Ltd?

For dividend-paying alternatives in Telix Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.